TuHURA Biosciences, Inc. HURA
- IFx-2.0 — Merkel Cell Carcinoma Phase 3
- IFx-2.0 — Cutaneous Melanoma Phase 1
- IFx-2.0 — Merkel Cell Carcinoma of Unknown Primary Origin Phase 1
TLR-2 (1 companies · 3 programs)
Companies with an active program directed at TLR-2.